Showing results (401-410 of 668) with videos related to
Sort By:
Pageof 67
Diabetology International|September 19, 2022
Cases of fulminant type 1 and type 2 diabetes mellitus whose HbA1c levels were unmeasurable due to increased labile HbA1cShunsuke Kato, Izumi Otaka, Hanako Toyama, et al.Diabetology International|March 25, 2024
Identification of causative gene variants for patients with known monogenic diabetes using a targeted next-generation sequencing panel in a single-center studyKaoru Takase, Shinji Susa, Hidenori Sato, et al.Diabetology International|March 25, 2024
Glycemic control and dementia risk in patients aged above and below 75 yearsHae Hyuk JungDiabetology International|March 25, 2024
Two patients with α-chain hemoglobin variant Hb Q-Iran detected by measuring hemoglobin A1c using the variant mode of the HA-8180V HPLC analyzerMaki Kinoshita, Daiki Shimomura, Masashi Shimada, et al.Diabetology International|March 25, 2024
Rapid improvement of severe fatty liver in a case of fulminant type 1 diabetes following insulin treatmentSonomi Noda, Nozomi Harai, Saki Komai, et al.Diabetology International|March 25, 2024
Practice of complementary and alternative medicine use in North Indian children with type 1 diabetes: an exploratory studyPriyanka Walia, Latika Rohilla, Devi DayalDiabetology International|January 24, 2024
The Japanese version of Problem Areas in Diabetes Scale: a clinical and research tool to assess emotional functioning among people with diabetesYasuaki Hayashino, Masashi Goto, Toshikazu Yamamoto, et al.Diabetology International|January 24, 2024
Correction: Trends in clinical characteristics and factors associated with initial prescription of SGLT2 inhibitors in Japanese patients with type 2 diabetes mellitusHiroshi Takahashi, Yuka Suganuma, Takayuki Ohno, et al.Diabetology International|January 24, 2024
Association of scan frequency with CGM-derived metrics and influential factors in adults with type 1 diabetes mellitusNaoki Sakane, Yushi Hirota, Akane Yamamoto, et al.Diabetology International|October 2, 2023
Anti-GAD antibody-positive fulminant type 1 diabetes developed following SARS-CoV-2 vaccinationTomohito Izumi, Hironobu Takahashi, Hironori TakahashiPageof 67